Three-dimensional human skin equivalent as a tool to study Acinetobacter baumannii colonization

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 5, 2012, Pages 2459-2464

  De Breij, Anna ^a   Haisma, Elisabeth M ^a   Rietveld, Marion ^a   El Ghalbzouri, Abdelouahab ^a   Van Den Broek, Peterhans J ^a   Dijkshoorn, Lenie ^a   Nibbering, Peter H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; DISINFECTANT AGENT;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BIOFILM; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INFECTION CONTROL; INFLAMMATION; KERATINOCYTE; PRIORITY JOURNAL; SKIN; SKIN DECONTAMINATION; STRATUM CORNEUM; THREE DIMENSIONAL IMAGING;

ACINETOBACTER; ACINETOBACTER BAUMANNII; BACTERIAL ADHESION; BIOFILMS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CHLORHEXIDINE; COLONY COUNT, MICROBIAL; CYTOKINES; DISINFECTANTS; GENE EXPRESSION; HUMANS; KERATINOCYTES; MIDDLE AGED; SKIN;

EID: 84860120718     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05975-11     Document Type: Article

References (24)

1. Bergogne-Berezin E, Towner KJ. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165. (Pubitemid 26123943)
2. Borer A, et al. 2007. Impact of 4% chlorhexidine whole-body washing on multidrug-resistant Acinetobacter baumannii skin colonisation among patients in a medical intensive care unit. J. Hosp. Infect. 67:149-155. (Pubitemid 47534969)
3. Bouvet PJ, Grimont PA. 1987. Identification and biotyping of clinical isolates of Acinetobacter. Ann. Inst. Pasteur Microbiol. 138:569-578. (Pubitemid 17149796)
4. Brooks SE, Walczak MA, Hameed R, Coonan P. 2002. Chlorhexidine resistance in antibiotic-resistant bacteria isolated from the surfaces of dispensers of soap containing chlorhexidine. Infect. Control Hosp. Epidemiol. 23:692-695. (Pubitemid 35315994)
5. de Breij A, et al. 2010. Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii? PLoS One 5:e10732.
6. Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5:939-951. (Pubitemid 350131182)
7. Dijkshoorn L, Van Vianen W, Degener JE, Michel MF. 1987. Typing of Acinetobacter calcoaceticus strains isolated from hospital patients by cell envelope protein profiles. Epidemiol. Infect. 99:659-667. (Pubitemid 18034339)
8. Dijkshoorn L, et al. 1989. Use of protein profiles to identify Acinetobacter calcoaceticus in a respiratory care unit. J. Clin. Pathol. 42:853-857. (Pubitemid 19190757)
9. Duckney P, Wong HK, Serrano J, Oddos T, Stamatas G. 2011. Inflammatory effects of common skin microbial species on cultured keratinocytes. J. Invest. Dermatol. 131(Suppl):S12.
10. El Ghalbzouri A, Commandeur S, Rietveld MH, Mulder AA, Willemze R. 2009. Replacement of animal-derived collagen matrix by human fibroblast-derived dermal matrix for human skin equivalent products. Biomaterials 30:71-78.
11. El Ghalbzouri A, Siamari R, Willemze R, Ponec M. 2008. Leiden reconstructed human epidermal model as a tool for the evaluation of the skin corrosion and irritation potential according to the ECVAM guidelines. Toxicol. In Vitro 22:1311-1320.
12. Evans HL, et al. 2010. Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. Arch. Surg. 145:240-246.
13. Gaddy JA, Actis LA. 2009. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol. 4:273-278.
14. Hidalgo E, Dominguez C. 2001. Mechanisms underlying chlorhexidine-induced cytotoxicity. Toxicol. In Vitro 15:271-276. (Pubitemid 32889643)
15. Khan MN, Naqvi AH. 2006. Antiseptics, iodine, povidone iodine and traumatic wound cleansing. J. Tissue Viability 16:6-10.
16. Lucarotti ME, White H, Deas J, Silver IA, Leaper DJ. 1990. Antiseptic toxicity to breast carcinoma in tissue culture: an adjuvant to conservation therapy? Ann. R. Coll. Surg. Engl. 72:388-392. (Pubitemid 20365549)
17. Marchaim D, et al. 2007. Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J. Clin. Microbiol. 45:1551-1555. (Pubitemid 46762412)
18. Nemec A, et al. 2011. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res. Microbiol. 162:393-404.
19. O'Toole G, Kaplan HB, Kolter R. 2000. Biofilm formation as microbial development. Annu. Rev. Microbiol. 54:49-79.
20. Shepherd J, Douglas I, Rimmer S, Swanson L, MacNeil S. 2009. Development of three-dimensional tissue-engineered models of bacterial infected human skin wounds. Tissue Eng. Part C Methods 15:475-484.
21. Thakoersing VS, et al. 18 October 2011, posting date. Unravelling barrier properties of three different in-house human skin equivalents. Tissue Eng. Part C Methods. [Epub ahead of print.] doi:10.1089/ten.TEC.2011.0175.
22. Urban C, Segal-Maurer S, Rahal JJ. 2003. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin. Infect. Dis. 36:1268-1274. (Pubitemid 36629937)
23. Visca P, Seifert H, Towner KJ. 18 October 2011, posting date. Acinetobacter infection - an emerging threat to human health. IUBMB Life. [Epub ahead of print.] doi:10.1002/iub.534.
24. Zeana C, et al. 2003. The epidemiology of multidrug-resistant Acinetobacter baumannii: does the community represent a reservoir? Infect. Control Hosp. Epidemiol. 24:275-279. (Pubitemid 36538140)